Excellent 10-Year Outcomes After Early Treat-to-Target in Rheumatoid Arthritis
(MedPage Today) -- Most patients with rheumatoid arthritis (RA) whose initial treatment used a stringent treat-to-target strategy in a clinical trial were in remission 10 years later, with only modest radiographic progression over that time, researchers...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.